Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 418,626 |
|
|||||
| News | - | ||||||
| Day High | 12.27 | Low High |
|||||
| Day Low | 11.49 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Stoke Therapeutics Inc | STOK | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.26 | 2.22% | 11.95 | 11:55:39 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 11.69 | 11.49 | 12.27 | 11.69 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,328 | 418,626 | $ 11.92 | $ 4,989,056 | - | 3.35 - 16.3999 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:56:04 | 100 | $ 11.95 | USD |
Stoke Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 533.17M | 44.65M | - | 8.78M | -104.7M | -2.34 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Stoke Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical STOK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 11.55 | 12.27 | 10.90 | 11.59 | 994,484 | 0.40 | 3.46% |
| 1 Month | 13.22 | 13.89 | 10.90 | 12.38 | 1,083,533 | -1.27 | -9.61% |
| 3 Months | 4.84 | 16.3999 | 4.09 | 11.39 | 1,283,254 | 7.11 | 146.90% |
| 6 Months | 3.51 | 16.3999 | 3.35 | 10.36 | 705,272 | 8.44 | 240.46% |
| 1 Year | 8.21 | 16.3999 | 3.35 | 9.51 | 518,850 | 3.74 | 45.55% |
| 3 Years | 32.21 | 41.60 | 3.35 | 13.28 | 341,315 | -20.26 | -62.90% |
| 5 Years | 27.21 | 71.58 | 3.35 | 17.72 | 272,944 | -15.26 | -56.08% |
Stoke Therapeutics Description
| Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. |
